The public registers hold a second record for Ruyuan Hec Pharm. The fuller profile, with 43 active US DMFs and 4 valid CEPs, is at HEC Pharm. Figures on this page cover only this record.
Ruyuan Hec Pharm is an API manufacturer based in China. It holds 21 active US drug master files across a filed portfolio of 20 molecules. Its GMP standing is certified by EMA and US FDA. Its most recent recorded inspection, by US FDA, closed on 22 November 2024 as NAI.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| China, China | 3009740510 |
| Shaoguan City, Ruyuan County, Guangdong Province, China | Not on file |
| Molecule | Regulators | Docs |
|---|---|---|
| Sitagliptin | SFDA (Saudi Arabia), US FDA | 4 |
| Fingolimod | SFDA (Saudi Arabia), US FDA | 2 |
| Rosuvastatin | US FDA | 2 |
| Alogliptin | US FDA | 1 |
| Apixaban | US FDA | 1 |
| Apremilast | US FDA | 1 |
| Aripiprazole | US FDA | 1 |
| Brivaracetam | US FDA | 1 |
| Escitalopram | US FDA | 1 |
| Linagliptin | US FDA | 1 |
| Linagliptin And | SFDA (Saudi Arabia) | 1 |
| Oseltamivir | US FDA | 1 |
| Prasugrel | US FDA | 1 |
| Ritonavir | US FDA | 1 |
| Rivaroxaban | US FDA | 1 |
| Sofosbuvir | SFDA (Saudi Arabia) | 1 |
| Solifenacin Succinate | US FDA | 1 |
| Sugammadex | US FDA | 1 |
| Tadalafil | US FDA | 1 |
| Vonoprazan | US FDA | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| MINSA (CR) | 2 | None |
| EMA | None | 1 |
| US FDA | None | 1 |
Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.
Choose your molecules and target markets. Ruyuan Hec Pharm comes back tiered against every other supplier able to file there.
Start for freeRanked by shared active ingredients where we have them, otherwise by country and comparable credentials.